Distinct Changes in Microbiota-Mediated Intestinal Metabolites and Immune Responses Induced by Different Antibiotics

Abstract

The cocktails of antibiotics are utilized to study the functions of microbiota. There have been studies on the alteration of not only the microbiota composition but also the host’s metabolism or immunity. However, the bacterial species associated with these altered physiologic markers are still unclear. Therefore, we supplied mice with drinking water containing ampicillin (AMP), vancomycin (VAN), neomycin (NEO), or metronidazole (MET) to observe the effect of each antibiotic on helper T cells and inflammation-related gene expression and metabolism, including amino acid metabolism and changes in gut microbiota. We observed major changes in gut microbiota in mice treated with AMP and VAN, respectively, immediately after administration. The abundance of the genera Parabacteroides and Akkermansia increased in the AMP and VAN groups, while Prevotella almost disappeared from both groups. The compositional changes in intestinal metabolites in the AMP and VAN groups were more distinct than those in the NEO and MET groups, which was similar to the microbiome results. In particular, the most distinct changes were observed in amino acid related metabolism in AMP and VAN groups; the amounts of phenylalanine and tyrosine were increased in the AMP group while those were decreased in the VAN group. The changed amounts of intestinal amino acids in each of the AMP and VAN groups were correlated with increases in the abundance of the genera Parabacteroides and Akkermansia in the AMP and VAN groups, respectively. The most distinctive changes in intestinal gene expression were observed in the ileum, especially the expression Th17-related genes such as rorgt, il17a, and il17f, which decreased dramatically in the guts of most of the antibiotic-treated groups. These changes were also associated with a significant decrease in Prevotella in both the AMP and VAN groups. Taken together, these findings indicate that changes in gut microbiota as well as host physiology, including host metabolism and immunity, differ depending on the types of antibiotics, and the antibiotic-induced gut microbiota alteration has a correlation with host physiology such as host metabolic or immunological status. Thus, the immune and metabolic status of the host should be taken into account when administering antibiotics.

Early antibiotics and risk for necrotizing enterocolitis in premature infants: A narrative review

“…For example, in vitro studies revealed that gentamicin, a first-line antibiotic drug of choice for neonatal sepsis, can directly inhibit the chemotactic response of human polymorphonuclear leukocytes ( 99 ). In another study, mice given Ampicillin or Vancomycin, two other antibiotics commonly used in neonates, exhibited significant downregulation of Th17-related genes in the ileum ( 100 ). In the piglet model of NEC, 5 days of antibiotic treatment resulted in significant downregulation of genes related to inflammation and innate immune response following compared to controls ( 45 ).…”

Microbiota and Glucidic Metabolism: A Link with Multiple Aspects and Perspectives

“…These changes were associated with improvements in baseline insulin values and insulin resistance in overweight and obese adults [ 143 ]. All three metabolites (TMAO, choline, and L-carnitine) have been associated with diabetes and gut-microbiota activity [ 144 , 145 ].…”